logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Healthcare Services
Filter

Healthcare Services

Categories

Sectors

Locations

Exchange

迈兰 克力芝 吉利德 孤儿药 瑞德昔韦

Healthcare Roundup – Mylan waives exclusive U.S. rights to generic Kaletra, Gilead to withdraw Orphan Drug tag for remdesivir

Mar 25, 2020

Life Science

Sorrento 迈博药业 新冠病毒 新冠肺炎

Sorrento Collaborates with Mabpharm on Development and Commercialization of Ace-Mab™ to Potentially Treat COVID-19

Mar 25, 2020

Life Science

Ovation Science (CSE OVAT)

Ovation Science Inc. Grants Stock Options

Mar 25, 2020

Life Science

吉利德瑞德昔韦将委托中国企业制造,复制瑞德昔韦属谣言

Gilead Mulls Hiring Remdesivir OEMs in China if Drug Passes Clinical Trials

Mar 25, 2020

Life Science

特朗普 恢复营业 新冠病毒

Healthcare Roundup –Trump would like country open for business by Easter Sunday, U.S. coronavirus cases near 47K

Mar 24, 2020

Life Science

来凯 诺华 FAZ053

Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset

Mar 24, 2020

Life Science

Dynavax 三叶草 新冠病毒

Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant

Mar 24, 2020

Life Science

乐普医疗AI-ECG Tracker

Lepu Medical Technology’s AI-ECG Tracker Gains US FDA’s Seal

Mar 24, 2020

Life Science

吉利德 瑞德昔韦 COVID-19 新冠病毒 疟疾药物

Healthcare Roundup – Gilead’s remdesivir wins orphan drug status for coronavirus, New York launches use of malaria drug to treat Covid-19

Mar 23, 2020

Life Science

协同作战,亚马逊配送新冠病毒自检包

Amazon will deliver and pick up at-home test kits provided by new coronavirus program in Seattle

Mar 23, 2020

Life Science

亚盛医药美国进行的Bcl-2抑制剂试验完成首位患者给药

Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States

Mar 23, 2020

Life Science

中国葆元生物抗癌药获临床批准

Chinese Center for Drug Evaluation (CDE) Cleared Taletrectinib IND and Issued Clinical Trial Authorizations for Two Phase 2 Clinical Trials in China

Mar 23, 2020

Life Science

美国新冠病毒 病例 3M 口罩

Healthcare Roundup – U.S. coronavirus cases top 15K as more testing becomes available, 3M beefs up production of respirators to meet coronavirus demand

Mar 21, 2020

Life Science

预防感染演变为重症新冠肺炎,Sorrento Therapeutics的STI-4398将进入测试

Sorrento Develops STI-4398 (Covidtrap™ Protein) For Potential Prevention And Treatment Of SARS-COV-2 Coronavirus Disease (COVID-19)

Mar 20, 2020

Life Science

世卫组织:正在研制至少20种新冠病毒疫苗,确保人人接种

WHO officials say at least 20 coronavirus vaccines are in development in global race for cure

Mar 20, 2020

Life Science

Ovation Science (CSE OVAT)

Ovation Science Inc. Grants Stock Options

Mar 20, 2020

Life Science

梯瓦制药 冠状病毒 疟疾药物,意大利 疫情

Healthcare Roundup – Teva to donate 6M doses of malaria drug for coronavirus use, Italy now world’s #1 Covid-19 hotspot

Mar 20, 2020

Life Science

Ovation Science (CSE OVAT)

Ovation Science Ramps-Up Its Manufacturing of DermSafe as Health Canada Takes Action to Increase the Supply of Hand Sanitizers to Manage the Spread of Coronavirus COVID-19

Mar 19, 2020

Life Science

  • ‹‹ Previous
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada